← Back to latest intelligence

Bulgaria’s spending on generic medicines drastically below EU average [Partner Content]

Editorial abstract

Generic medicines account for 75% of pharmaceutical sales by volume in Bulgaria with less than 10% of public funding

This is not the publisher’s original article. Unreviewed abstracts are mechanically condensed from source-provided material; editor-reviewed abstracts have completed editorial review.

Story classification

Topics

Economic Policy · Low confidence · AutomaticBroad source default; editorial correction recommended

Regions

Europe · High confidence · AutomaticStory-text location match

Read original at Euractiv ↗